نتایج جستجو برای: standard heparin

تعداد نتایج: 544724  

Journal: :Archives of internal medicine 1999
B O'Brien M Levine A Willan R Goeree S Haley G Blackhouse M Gent

BACKGROUND The safety and efficacy of taking low-molecular-weight heparin at home was previously demonstrated in a clinical trial in which patients with acute proximal deep vein thrombosis were randomized to receive either intravenous standard heparin in the hospital or subcutaneous low-molecular-weight heparin administered primarily at home. Treatment in the home has the potential to substanti...

Journal: :Kidney international 2014
Maurice Laville Marc Dorval Joan Fort Ros Renaud Fay Joëlle Cridlig Joëlle L Nortier Laurent Juillard Alicja Dębska-Ślizień Loreto Fernández Lorente Damien Thibaudin Casper Franssen Michael Schulz Frédérique Moureau Nathalie Loughraieb Patrick Rossignol

Heparin is used to prevent clotting during hemodialysis, but heparin-free hemodialysis is sometimes needed to decrease the risk of bleeding. The HepZero study is a randomized, multicenter international controlled open-label trial comparing no-heparin hemodialysis strategies designed to assess non-inferiority of a heparin grafted dialyzer (NCT01318486). A total of 251 maintenance hemodialysis pa...

2000
James E. Tcheng Mohan V. Bala Linda Davidson-Ray

Background—In the EPILOG trial (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade), abciximab administered with weight-adjusted heparin diminished the risk of ischemic complications within 30 days by 56% among patients undergoing percutaneous coronary revascularization, without increased bleeding complications. Methods and Results—A prospective economic assessm...

2000
A. Michael Lincoff James E. Tcheng Linda Davidson-Ray

Background—In the EPILOG trial (Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade), abciximab administered with weight-adjusted heparin diminished the risk of ischemic complications within 30 days by 56% among patients undergoing percutaneous coronary revascularization, without increased bleeding complications. Methods and Results—A prospective economic assessm...

Journal: :The journal of extra-corporeal technology 1996
T D Clark J M Ecklund M M McCall D R Wolk J B Riley

Three available methods used to determine heparin loading dose were studied to determine the most reliable method for reaching a target pre-bypass activated clotting time (ACT) of 510 seconds. One hundred and seven patients were randomly assigned to one of three treatment methods: A) 300 units/kg; B) Hemostasis Management System (HMS); C) RX/DX. Five different lots of heparin were assigned to G...

Journal: :Haemostasis 1984
J van Putten M van de Ruit M Beunis H C Hemker

The applicability was investigated of automated spectrophotometric heparin assays and three clotting assays for determination of two low molecular weight (LMW) heparin fractions: Org 10172 and DxN10 and two infractionated commercially available heparins. The relative activity of the two commercially available heparins was similar in the anti-Xa assay, in the anti-IIa assay and in 3 clotting ass...

Journal: :Blood 1988
J Pieters T Lindhout

The antifactor Xa activities of heparin fractions are widely used as an ex vivo index of their antithrombotic efficacy. Its clinical meaning, however, remains speculative. In the study reported, we measured the effects of standard heparin, a synthetic pentasaccharide heparin (antifactor Xa activity only), and a low molecular weight heparin (LMWH) on factor Xa, factor Va, and thrombin generation...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید